Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
The protein encoded by CTAG1B is an antigen that is overexpressed in many cancers but that is also expressed in normal testis. De plus, nous expédions Cancer/testis Antigen 1B Kits (6) et Cancer/testis Antigen 1B Protéines (2) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 122 products:
Human Polyclonal CTAG1B Primary Antibody pour ELISA, WB - ABIN570720
Shan, Lou, Xiao, Zhang, Sun, Gao, Cheng, Wu, Xu, Liu: A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer. dans Cancer letters 2012
Human Polyclonal CTAG1B Primary Antibody pour ELISA, MA - ABIN4265165
Adams, ONeill, Nonaka, Hardin, Chiriboga, Siu, Cruz, Angiulli, Angiulli, Ritter, Holman, Shapiro, Berman, Berner, Shao, Manches, Pan, Venhaus, Hoffman, Jungbluth, Gnjatic, Old, Pavlick, Bhardwaj: Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. dans Journal of immunology (Baltimore, Md. : 1950) 2008
A significant association was found between AKAP4 (Montrer AKAP4 Anticorps) gene expression and metastasis (P-value: 0.045), expression of the CTAG1B (NY-ESO-1) gene was not observed in our cases.
In 22 melanoma patients with stage III lymph node metastasis, overall survival was significantly higher in the XAGE-1b and NY-ESO-1 double-negative group than in the other groups.
The present results indicate the strong humoral immune response against NY-ESO-1 in natural human T-cell leukemia virus type 1 infection, irrespective of the clinical status.
some autoantibodies, such as anti-MAGEA4 (Montrer MAGEA4 Anticorps), anti-CTAG1 or anti-TP53 (Montrer TP53 Anticorps) and their combinations could possibly contribute to the development of cancer early detection tests (not necessarily restricted to gastric cancer) when being combined with other markers.
High NY-ESO-1 expression is associated with Lung Cancer.
Results support the potential utility of NY-ESO-1, PRAME (Montrer PRAME Anticorps), and MAGEA4 (Montrer MAGEA4 Anticorps) as targets for immunotherapy and as ancillary prognostic parameters in synovial sarcomas.
Data suggest that only a small fraction of HLA-A*02:01- (HA)-binding ESO peptides are immunogenic, namely those that have high peptide-binding strength and peptide/HA complex stability. This study involved comparison of in silico-predicted and observed cytotoxic T-lymphocyte recognition of tumor antigen epitopes in melanoma patients and transgenic/knockout mice. (ESO = tumor antigen NY-ESO-1)
These data demonstrate that MAGE (Montrer MAGEB10 Anticorps)-A1-, MAGE-A3 (Montrer MAGEA3 Anticorps)-, and NY-ESO-1-specific T cells with antigen-specific cytotoxicity can be cultured from healthy donors and patient-derived cells making adoptive immunotherapy with these cytotoxic T lymphocyte feasible.
Comparing the overall expression of CTAs, a decreased expression of all melanoma-associated (Montrer ZNF654 Anticorps) antigens (MAGEs) post-treatment and a slightly increased expression of New York esophageal squamous cell carcinoma 1 (NY-ESO-1) was visible. The simultaneous cytoplasmic and nuclear expression of pan (Montrer SUPT6H Anticorps)-MAGE (Montrer MAGEB10 Anticorps) or MAGE-A3 (Montrer MAGEA3 Anticorps)/A4 correlated with reduced treatment-failure-free-survival (TFFS).
MAGE (Montrer MAGEB10 Anticorps)-A is more highly expressed than NY-ESO-1 in a majority of human malignancies
The protein encoded by this gene is an antigen that is overexpressed in many cancers but that is also expressed in normal testis. This gene is found in a duplicated region of the X-chromosome and therefore has a neighboring gene of identical sequence.
New York esophageal squamous cell carcinoma 1
, autoimmunogenic cancer/testis antigen NY-ESO-1
, cancer antigen 3
, cancer/testis antigen 1
, cancer/testis antigen 6.1
, l antigen family member 2